search
ADARx
Trends
- 1ADARx raises $446.3 million in IPO▼ADARx bags $446.3M IPO as another siRNA startup readies for its debut
RNA-focused biotech ADARx has priced an initial public offering raising $446.3 million, a strong showing for a genetic-medicine startup. The listing comes as another siRNA company prepares its own stock market debut, signalling renewed investor appetite for RNA interference platforms after a lean stretch for biotech offerings.